Besides, GSK3-β inhibitors 9-ING-41 and 9-ING-87, can suppress the growth of breast cancer cells in vitro and in vivo, and can also sensitize breast cancer patient-derived tumour xenografts to a chemotherapeutic agent irinotecan [24]. The gene discussed is GSK3B; the disease is breast carcinoma.